LABD ETF: Direxion Daily S&P Biotech Bear 3X ETF - Price, Holdings & Analysis
Direxion Daily S&P Biotech Bear 3X ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About Direxion Daily S&P Biotech Bear 3X ETF
What is the current price of LABD?
The latest LABD price is $6.45. The 52-week range is $5.81–$51.90. LABD has returned -86.5% over the past 52 weeks.
What is the expense ratio for LABD?
LABD's annual expense ratio is 1.07%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does LABD pay dividends?
Yes, LABD pays a 24.33% dividend yield. The last ex-dividend date was 2026-09-30. View full dividend history in the Dividends section.
What are the top holdings of LABD?
LABD's largest holdings are Dreyfus Government Cash Management Funds - Dreyfus Government Securities Cash Management (65.0%), Goldman Sachs Financial Square Government Fund Institutional Shares (12.6%) (combined weight: 77.6%). The fund holds 13 total positions. View the complete portfolio breakdown in the Holdings section.
How does LABD compare to similar ETFs?
Compare LABD (1.07% expense ratio, $65M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.